ReviewTouchREVIEWS in endocrinology2024

Osilodrostat: A Novel Potent Inhibitor of 11-Beta-Hydroxylase for the Treatment of Cushing's Syndrome.

Rosario Pivonello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.